We are live on ! Find out more
ZYME icon

Zymeworks

183 hedge funds and large institutions have $1.26B invested in Zymeworks in 2025 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 61 increasing their positions, 65 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

116% more call options, than puts

Call options by funds: $9.15M | Put options by funds: $4.24M

33% more capital invested

Capital invested by funds: $949M → $1.26B (+$310M)

1% more funds holding

Funds holding: 181183 (+2)

9% more first-time investments, than exits

New positions opened: 25 | Existing positions closed: 23

6% less repeat investments, than reductions

Existing positions increased: 61 | Existing positions reduced: 65

10.63% less ownership

Funds ownership: 108.68%98.05% (-11%)

40% less funds holding in top 10

Funds holding in top 10: 53 (-2)

Holders
183
Holders Change
+2
Holders Change %
+1.1%
% of All Funds
2.4%
Holding in Top 10
3
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-40%
% of All Funds
0.04%
New
25
Increased
61
Reduced
65
Closed
23
Calls
$9.15M
Puts
$4.24M
Net Calls
+$4.92M
Net Calls Change
+$1.6M

ZYME Hedge Fund Activity: Q3 2025 in Review

183 of the 7,621 institutional investors tracked by Wall St. Rank reported a position in Zymeworks (ZYME) for Q3 2025, worth a combined $1.26B — up 33% from $949M a quarter earlier.

Buyers outnumbered sellers: 25 funds opened new ZYME positions and 23 closed out — a net gain of 2 holders — while 61 added to existing stakes and 65 trimmed.

The largest buyer was Millennium Management, adding an estimated $14.2M. The largest seller was BNP Paribas Asset Management, exiting entirely with an estimated $25.6M sold.

  • 183 institutional investors held Zymeworks (ZYME) as of Q3 2025, up from 181 in Q2 2025.
  • Funds reported $1.26B of Zymeworks stock for Q3 2025, up 33% quarter-over-quarter.
  • 25 funds opened new Zymeworks positions in Q3 2025 and 23 closed out, a net change of +2 holders.
  • The largest Zymeworks buyer in Q3 2025 was Millennium Management, an estimated $14.2M added.
  • The largest Zymeworks seller in Q3 2025 was BNP Paribas Asset Management, an estimated $25.6M sold.

Based on aggregated 13F filings for Q3 2025.